Article
Published 1 May 2025
Judge Blocks FDA Regulation Of Laboratory-Developed Tests
Jones Day
Your search returned 6,070 results
Refine Your Search
Search Results
- Relevance
- Newest
- Oldest
Article
Published 30 Apr 2025
Regeneron, Mylan, And Biocon Settle In Aflibercept BPCIA Litigation
Goodwin Procter LLP
Article
Published 30 Apr 2025
National Security Commission On Emerging Biotechnology's Final Report Includes Recommendations To Boost Economy And Protect National Security
Bergeson & Campbell
Article
Published 30 Apr 2025
False Claims Act Enforcement: Looking Back And What To Expect In 2024
Foley Hoag LLP
Article
Published 29 Apr 2025
BIS Initiates 232 Investigations Of Pharmaceuticals And Semiconductors
Diaz Trade Law
Article
Published 28 Apr 2025
Navigating The Rise Of Accommodation Requests In Life Sciences (Podcast)
Jackson Lewis P.C.
Article
Published 28 Apr 2025
Charting A Conditional Approval Pathway For Rare Disease Drugs – A Top Priority For A Revamped FDA?
Goodwin Procter LLP
Article
Published 28 Apr 2025
Skilled Nursing Facilities: CMS Extends Medicare Revalidation Deadline
Foley & Lardner
Article
Published 27 Apr 2025
Vanda Pharmaceuticals Inc. v. FDA: Industry's Latest Attempt To Clarify Off-Label Promotion Rules
Steptoe LLP
Article
Published 25 Apr 2025
Five Trends Reshaping Pharmaceutical Manufacturing Partnerships
Goodwin Procter LLP
Article
Published 25 Apr 2025
Off-Cycle Medicare Revalidations For SNFs – Deadline Extended To August 1, 2025
Benesch Friedlander Coplan & Aronoff LLP
Article
Published 25 Apr 2025
Procedural Changes To Registered European Union Designs
J A Kemp LLP
Article
Published 25 Apr 2025
Life Sciences In The Crosshairs Of Disruption
AlixPartners
Article
Published 25 Apr 2025
Standard-Essential Patent Licensing Comes To Medtech
WilmerHale
Article
Published 25 Apr 2025
Virginia Amends Consumer Protection Act To Protect Reproductive And Sexual Health Information
WilmerHale
Article
Published 24 Apr 2025
FDA Approves Biocon Biologics' Bevacizumab Biosimilar
Goodwin Procter LLP
Article
Published 24 Apr 2025
MedTech Round Table: What The Trump Administration Means For Companies And Investors
Foley & Lardner
Article
Published 24 Apr 2025
Arkansas Adopts First-of-Its-Kind Bill Blocking PBMs From Owning Pharmacies, As State Attorneys General Urge Similar Congressional Action
Duane Morris LLP
Article
Published 24 Apr 2025
Where Does Rare Disease And Patient-Focus Fall Into Commissioner Makary's Priorities & The MAHA Platform For FDA? A New Ultrarare Approval Pathway & More
Hyman, Phelps, & McNamara
Article
Published 24 Apr 2025
Focus On PBMs Garners Bipartisan Alliance
Duane Morris LLP